Today, Absci announced that its generative AI model has been able to create an entirely new antibody in software using E. coli bacteria.
View Article on VentureBeat
AI,Absci,AI, ML and Deep Learning,category-/Science/Computer Science,drug discovery,Generative AI,healthcare AI,large language models,NVidia,supervised learning,training AI models,unsupervised learning
unsupervised learning